Longevity Medicine Specialist
NicheAlso known as: Anti-Aging Medicine Doctor, Longevity Physician, Healthspan Optimization Specialist
Work as a physician focused on healthspan — using biomarkers, imaging and continuous monitoring to find and cut disease risk years before symptoms appear. There is no separate longevity degree: you train as a doctor, usually in internal medicine, then specialise. Most of the work is cash-pay, so most of the patients are wealthy.
BLS has no code for this job. Its 4% figure covers Physicians and Surgeons as a whole, which is a far broader group doing mostly unrelated work. We think this niche grows faster, and the reasons are dated: ABMS recognised Lifestyle Medicine as a focused practice designation in August 2026, the first institutional foothold this work has ever had; Mayo, Cleveland Clinic and Mount Sinai have all launched programmes; and the best-known private practice is hiring in quarterly cohorts into 2027 against a growing waitlist. Worth knowing the other half of the picture: geriatrics, the accredited and boarded version of ageing medicine, filled only 38.9% of its fellowship places in the 2026 match — the lowest of any internal medicine subspecialty. The accredited version cannot fill its seats while the cash-pay version is the most fashionable thing in medicine. The difference is not the science. It is who pays.
What would change our mind: If the ABMS Lifestyle Medicine eligibility rules land narrow when they are finalised, or cash-pay demand cools with the wealth cycle, this reverts to internal medicine with a better website.
Salary Range
The highest-paid specialization or seniority level for longevity medicine specialists.
About 1 in 20 reaches this level
Nobody counts US longevity physicians — there is no BLS code and no census. The field is roughly 3,000 US physicians (est., no BLS code — subset of SOC 29-1210); the two published anchors are both global, not national: 1,200+ self-reported Longevitydocs members worldwide (2026) and 590 physicians worldwide who had completed the leading academic curriculum by March 2024 (JMIR Med Educ, 2026). Of that estimated field, perhaps 5% (~150) own a cash-pay practice earning $750,000 or more. Employment tops out far lower, near $400,000 — Early Medical publishes $350-400K for a senior staff physician.
Salary data based on 2025 BLS, Glassdoor, and industry reports. Actual compensation varies by location, experience, and employer.
How to Become One
This career typically requires a doctoral/professional degree. Here are the top colleges for it:
Cost to Qualify
Four years of medical school tuition and fees, on top of a four-year bachelor's: about $159,000 at a public school in your own state and $282,000 at a private one, with public out-of-state in between at roughly $261,000. Living costs are not included. Residency afterwards (3-7 years) is a paid job, not a bill. AAMC's lowest reported tuition is $0 - a few schools now charge none - which is why its average ($61,626 private resident) sits below its median ($68,176). Cost-to-salaryEntry ratio is 3.1x against the $68,000 entry salary we list for physicians (a resident's pay, not an attending's) - well above the 2.0 line, and expected for medicine. These totals hold first-year tuition flat across four years. Tuition rose 2.0-2.4% year over year in the latest round, so a student starting in 2026 should expect roughly 5-6% more than the figure shown.
Sticker price, not what most people pay — scholarships, aid and in-state status all move it. Room and board is shown separately on each college's page.
AI Risk Assessment
Longevity doctors try to find and cut disease risk years before symptoms show, using blood tests, imaging and data from wearables. Much of that is data work, and AI is already part of it. A 2024 paper in the journal Aging, written by researchers from the Aging Research and Drug Discovery meeting, describes how machine learning now combines many biomarkers into "ageing clocks" that estimate a person's biological age, and has helped find new biomarkers. Richard Barker, a health-innovation commentator, wrote in January 2026 that there is "intense activity" applying AI to personal healthspan plans, with new consumer products launched in 2025. His caution: the hard part is getting consistent, high-quality data, not the AI itself.
So part of this job, reading the numbers, is moving to software, and some of that software is sold straight to patients. The rest stays with the doctor: examining patients, prescribing, taking legal responsibility, and the long relationship that cash-paying patients are buying. A 2025 Microsoft Research study of AI chatbot use put general internal medicine physicians, the usual training route into this field, in the middle of 785 occupations (341st). The government has no category for longevity medicine. Physicians and surgeons as a whole are projected to grow 4% from 2025 to 2035, about average, with about 22,100 openings a year.
The market is real but uneven. Barker describes "scores of individual and largely commercially oriented clinics" and says progress in 2025 was "real but fragmentary," with most anti-aging treatment self-pay and "restricted to the affluent." That is a business risk, not an AI one.
We keep this at 2, the same as physicians generally. What would change the score: consumer AI services good enough that people skip the doctor for biomarker review, or clinics using AI to stretch one physician across many more patients, would push it to 3.
Sources
Ratings reflect a 10-year outlook based on 2025-2026 research, weighted toward entry-level impact. Individual outcomes will vary.
Related Careers
Is Longevity Medicine Specialist right for you?
Take our free 20-minute assessment to find out if longevity medicine specialist matches your personality, interests, and strengths.
Take the Free Assessment